OCULAR MYASTHENIA GRAVIS
Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for eye muscle weakness: Long-Term drug safety trial launches
Disease control Not yet recruitingThis study looks at the long-term safety and effectiveness of a drug called rozanolixizumab for adults with ocular myasthenia gravis, a condition that causes muscle weakness in the eyes. About 100 participants who have already taken the drug in a previous study will continue trea…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug trial aims to ease droopy eyelids and double vision
Symptom relief Not yet recruitingThis study tests an investigational drug called rozanolixizumab against a placebo in 120 adults with ocular myasthenia gravis, a condition causing eye muscle weakness. The main goal is to see if the drug improves symptoms like droopy eyelids or double vision after about 6 weeks. …
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated May 26, 2026 08:55 UTC